Add to ORKGCancer of cervix is the third most common cancer and the fourth leading cause of cancer death of women worldwide. It is estimated that cervical cancer contributes to approximately 9 % of the total new cancer cases and 8
Cervical cancer is the most frequent occurring gynaecologic malignancy world-wide. Approximately 492...
No validated tumor marker is currently available for the management of patients with cervical cancer...
Cervical cancer is an important cause of death in women worldwide. Infection with high-risk human pa...
Cervical cancer (CC) is a leading cause of deaths among women worldwide. It is the third most common...
Purpose: The purpose was to evaluate the prognostic significance of serum tumour markers and other p...
Ninety-one patients with adenocarcinoma of the cervix had 4 tumour markers (TMs) assayed before trea...
A review is given of the clinical use and interpretation of serum tumor marker levels during the tre...
Three hundred two patients with squamous cell carcinoma of the cervix had pretreatment measurement o...
Four antibodies (anti-CCA, anti-CEA, Ca-1, and anti-EMA) were used to study the distribution of anti...
Cervical cancer is the most common malignant tumor among the female population. More than 400 thousa...
Cervical cancer, a potentially preventable disease, remains the second most common malignancy in wom...
Cervical cancer is the second most common female cancer in Thailand. The treatment depends on the ...
OBJECTIVE: The aim of this study was to determine the correlation between SCC Ag and the prognosis i...
Purpose: To investigate the prognostic value of pretreatment serum squamous cell carcinoma antigen (...
Purpose: To investigate the prognostic value of pretreatment serum squamous cell carcinoma antigen (...
Cervical cancer is the most frequent occurring gynaecologic malignancy world-wide. Approximately 492...
No validated tumor marker is currently available for the management of patients with cervical cancer...
Cervical cancer is an important cause of death in women worldwide. Infection with high-risk human pa...
Cervical cancer (CC) is a leading cause of deaths among women worldwide. It is the third most common...
Purpose: The purpose was to evaluate the prognostic significance of serum tumour markers and other p...
Ninety-one patients with adenocarcinoma of the cervix had 4 tumour markers (TMs) assayed before trea...
A review is given of the clinical use and interpretation of serum tumor marker levels during the tre...
Three hundred two patients with squamous cell carcinoma of the cervix had pretreatment measurement o...
Four antibodies (anti-CCA, anti-CEA, Ca-1, and anti-EMA) were used to study the distribution of anti...
Cervical cancer is the most common malignant tumor among the female population. More than 400 thousa...
Cervical cancer, a potentially preventable disease, remains the second most common malignancy in wom...
Cervical cancer is the second most common female cancer in Thailand. The treatment depends on the ...
OBJECTIVE: The aim of this study was to determine the correlation between SCC Ag and the prognosis i...
Purpose: To investigate the prognostic value of pretreatment serum squamous cell carcinoma antigen (...
Purpose: To investigate the prognostic value of pretreatment serum squamous cell carcinoma antigen (...
Cervical cancer is the most frequent occurring gynaecologic malignancy world-wide. Approximately 492...
No validated tumor marker is currently available for the management of patients with cervical cancer...
Cervical cancer is an important cause of death in women worldwide. Infection with high-risk human pa...